Description: Synapse Research Institute is the inventor and patent holder of the “calibrated thrombin generation” and we are very proud that this calibrated TG is now the world standard for thrombin generation measurements. The CAT device measures both thrombotic and bleeding tendencies.
Synapse Research Institute was founded in 1999 as a research institute to explore thrombin generation (TG). Synapse is the inventor and patent holder of the “Calibrated Automated Thrombinography (CAT) assay”.
The CAT assay is able to detect both thrombotic and bleeding tendencies. There is increasing awareness amongst scientists and medical doctors that measuring TG can reflect the coagulation state of a patient in vitro.
The CAT assay can predict the bleeding or thrombotic risk in patients with e.g. haemophilia, coagulation factor deficiencies, (venous) thrombosis risk in patients with atrial fibrillation, cancer, APC-resistance and inflammatory disorders.
Links to synapseresearchinstitute.com (25)
stago.comAdvanced Hemostasis and Thrombosis Analysis Solutions Provider | Stago
stago.frSolutions avancées d'analyse de l'hémostase et de la thrombose | Stago France
stago-bnl.comAdvanced Hemostasis and Thrombosis Analysis Solutions Provider | Stago